EndeavorOTC® Research Study in College Students

Status unconfirmed · Not applicable

Conditions studied: Attention, Cognition, University Students

In brief

The objective of this study is to evaluate the impact of a digital therapeutic (EndeavorOTC®, also known as AKL-T01A) on clinical symptoms of executive and cognitive functioning in a real-world sample of university students. This study aims to answer whether EndeavorOTC represents a useful intervention for targeting broad cognitive and emotional health among university students.

Key facts

Study ID

NCT06376032

Run by

Akili Interactive Labs, Inc.

People needed

69

Starts

2024-01-10

Expected to finish

2025-12-31

Last updated by the study team

2024-06-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Owns a personal Android or iOS device to access AKL-T01 treatment
• Provides informed consent to participate in this study
• Is 18 years of age or older

You may not qualify if…

• Known photosensitive epilepsy, color blindness, and any physical limitation that would make engagement with an app-based digital intervention difficult
• Has participated in the same study in previous semesters
• Pregnant and nursing people are eligible to participate.

Where it is running

• Villa Maria College — Cheektowaga, New York, United States
• Landmark College — Putney, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.